Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …

Kelsey M. Jordan, J. Stewart Cameron1, Michael Snaith2, Weiya Zhang3, Michael Doherty3,
Jonathan Seckl4, Aroon Hingorani5, Richard Jaques6, George Nuki7 on behalf of the British …

Objectives To describe trends in the epidemiology of gout and patterns of urate-lowering
treatment (ULT) in the UK general population from 1997 to 2012. Methods We used the …

Objectives: To assess concordance of the management of chronic gout in UK primary care
with the European League Against Rheumatism (EULAR) gout recommendations. Methods …

Gout is the most common inflammatory arthritis and one in which pathogenesis and risk
factors are best understood. One of the treatment objectives in current guidelines is 'cure' …

Background Gout is estimated to affect 1.4% of adults in the UK. Appropriate and timely
management is essential to reduce the risk of further flares, complications, and to reduce …

Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

This review article summarizes the relevant English literature on gout from 2010 through
April 2017. It emphasizes that the current epidemiology of gout indicates a rising prevalence …

Background 1–2% of adults in Germany suffer from gout. Gout is one of the few
rheumatological diseases that can be cured. It arises through the deposition of uric acid …

Objectives The treat-to-target (T2T) concept has been applied successfully in several
inflammatory rheumatic diseases. Gout is a chronic disease with a high burden of pain and …